TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
BIOA

BioAge Labs, Inc

Healthcare · Drug Manufacturers - Specialty & Generic · —

8.10$ -0.4% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow BIOA
Line item 2013 2014 2015 2016 2017 2022 2023 2024 2025
-1,032.7% -1,455.1% -1,482.5% -454.7% -199.4% -907.5%
64.0% 88.6% 191.5% 110.7% 62.5% 2.4%
252.6% 450.4% 220.6% 43.3% 34.7% 130.0%
2,863.8% -2,784.0% -2,441.6% 59.9% 119.4% -131.5%
479.8% 0.0% 0.0% 0.0% 0.0% 8.0%
-1,058.5%
-3,141.5% -3,307.9% -321.1% -195.3% -31.0%
-66.7%
3,749.1% 5,097.3% 2,527.1% 570.9% 126.1% 127.5%
2,200.8% -2,118.2% -2,029.0% 111.0% -77.1% -1,839.5%
-1,512.6% -1,455.1% -1,482.5% -454.7% -199.4% -915.5%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?